The chart below shows how CG performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CG sees a +2.04% change in stock price 10 days leading up to the earnings, and a +2.78% change 10 days following the report. On the earnings day itself, the stock moves by -3.16%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Record Fee-Related Earnings: 1. Record Fee-Related Earnings: Carlyle achieved record quarterly fee-related earnings (FRE) of $278 million, representing a 36% increase compared to Q3 2023, with FRE margins reaching an all-time high of 47%.
Capital Raising Success: 2. Significant Capital Raising: The firm raised $9 billion in new capital during the quarter, contributing to a total of $43 billion raised over the past 12 months, with expectations for strong fundraising in Q4.
Private Equity Revenue Surge: 3. Strong Performance in Private Equity: The corporate private equity funds saw a nearly 30% increase in net accrued performance revenues, totaling $2.8 billion, which translates to approximately $8 per share of future earnings for shareholders.
Wealth Inflows Surge: 4. Record Wealth Inflows: Carlyle experienced record wealth inflows of $1.8 billion in the quarter, nearly three times the amount from the previous quarter, leading to a 70% year-over-year increase in global wealth AUM.
Share Repurchase Update: 5. Share Repurchase Program: The company repurchased $150 million of shares in Q3, bringing total repurchases to nearly $480 million year-to-date, with over $900 million remaining on the share repurchase authorization.
Negative
Declining Net IRR Performance: 1. Declining Net IRR: The net IRR for CP5 fell to 4%, indicating a significant drop in performance metrics despite an increase in accrued carry.
Management Fee Growth Analysis: 2. Subdued Management Fee Growth: Management fees grew only 2% year-on-year, reflecting a lack of substantial net asset growth amid larger outflows than fundraising.
Stock-Based Compensation Concerns: 3. High Stock-Based Compensation: Stock-based compensation is running between $120 million and $130 million, with expectations for a step-down in 2025, indicating potential future financial strain.
Stagnant Returns in Private Equity: 4. Underperformance in Corporate Private Equity: Despite strong EBITDA growth of 15% year-over-year, the net IRR in CP7 remained stagnant at 8%, suggesting challenges in translating performance into returns.
Share Repurchase vs. Growth: 5. Increased Share Repurchase but Limited Growth: While $150 million in shares were repurchased in Q3, the focus on organic growth may limit the ability to leverage excess capital for further expansion.
The Carlyle Group Inc. (CG) Q3 2024 Earnings Call Transcript
CG.O
1.1%